Why the terms are often confused
Public discussion frequently uses “Ozempic” as shorthand for an entire category of GLP-1 medicines. Medically, that is imprecise. The same molecule can appear in different products, while other GLP-1 medicines use different molecules altogether.
What is semaglutide?
Semaglutide acts on the GLP-1 pathway, which is involved in appetite, digestion and glucose regulation. It has been studied in type 2 diabetes and chronic weight management. The appropriate use depends on the specific product and its approved indication.
What is Ozempic?
Ozempic is a brand name for a semaglutide product. A brand identifies more than an ingredient: it is associated with a particular formulation, dosing presentation, delivery device and regulatory indication. That is why “Ozempic” and “semaglutide” should not be used as interchangeable medical terms.
Why this matters in India
As the Indian semaglutide market develops, patients may see more product names and price points. Comparing only the active molecule can miss important differences. Patients should check the exact product information and use medicines only under appropriate medical supervision.
Questions to clarify
- What is the exact product name?
- What active ingredient and strength does it contain?
- What is its approved indication?
- What dosing instructions apply to that product?
- What are its warnings and contraindications?
- How should it be stored and dispensed?
Frequently asked questions
Does every semaglutide product equal Ozempic?
No. Ozempic is a particular brand. Other products containing semaglutide are not automatically the same branded medicine.
Is every GLP-1 semaglutide?
No. GLP-1 describes a therapeutic mechanism/class and includes medicines with different active molecules.
Where can I learn more about semaglutide?
Read Vaya's India-focused semaglutide guide for an overview of the molecule, clinical assessment, dosing concepts, safety and cost considerations.